Graustein, A., Horne, D., Fong, J., Schwarz, F., Mefford, H., Peterson, G., . . . Hawn, T. (2017). The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes. Elsevier.
Chicago Style (17th ed.) CitationGraustein, A., et al. The SIGLEC14 Null Allele Is Associated with Mycobacterium Tuberculosis- and BCG-induced Clinical and Immunologic Outcomes. Elsevier, 2017.
ציטוט MLAGraustein, A., et al. The SIGLEC14 Null Allele Is Associated with Mycobacterium Tuberculosis- and BCG-induced Clinical and Immunologic Outcomes. Elsevier, 2017.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.